A detailed history of Tounjian Advisory Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Tounjian Advisory Partners, LLC holds 12,898 shares of JNJ stock, worth $2.57 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
12,898
Previous 17,524 26.4%
Holding current value
$2.57 Million
Previous $3.25 Billion 17.85%
% of portfolio
0.9%
Previous 1.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

SELL
$185.98 - $199.58 $860,343 - $923,257
-4,626 Reduced 26.4%
12,898 $2.67 Billion
Q3 2025

Nov 12, 2025

SELL
$155.17 - $185.42 $1.58 Million - $1.89 Million
-10,200 Reduced 36.79%
17,524 $3.25 Billion
Q2 2025

Jul 09, 2025

SELL
$146.36 - $159.82 $71,130 - $77,672
-486 Reduced 1.72%
27,724 $4.6 Billion
Q1 2025

Apr 14, 2025

BUY
$142.06 - $167.7 $4.01 Million - $4.73 Million
28,210 New
28,210 $4.68 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Tounjian Advisory Partners, LLC Portfolio

Follow Tounjian Advisory Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tounjian Advisory Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tounjian Advisory Partners, LLC with notifications on news.